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Abstract
Bacterially expressed nucleocapsid (N) protein, from respiratory syncytial virus (RSV), was used to investigate RNA binding in a
modified North–Western blotting protocol. The recombinant protein demonstrated no sequence specificity in binding RNA representing
either the antigenomic leader sequence or the nonspecific sequence derived from a plasmid vector. When recombinant N was purified on
CsCl gradients, two types of structure, both with densities indicating that they contained RNA, could be visualised by negative-stain electron
microscopy. Structures similar to nucleocapsids (NC) from RSV-infected cells were observed, as were ring structures. A small fragment of
the N (amino acids 1-92) was all that was required for the production of NC-like structures. Another mutant with an internal deletion could
form rings but not NC-like structures. This suggests that this domain (amino acids 121-160) may be important for maintaining helical
stability. Further analysis has also identified a potential site in the amino-terminus that may be involved in an interaction with the
phosphoprotein. A domain model of the RSV N protein is presented which, similar to that of other paramyxoviruses, supports the idea that
the amino-terminus is important for NC assembly.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Respiratory syncytial virus (RSV), a pneumovirus, has
a negative-sense RNA genome encapsidated by the nu-
cleocapsid (N) protein forming a helical nucleocapsid
(Collins et al., 2001). This ribonucleoprotein (RNP)
structure, as is the case for all members of the Monon-
egavirales, is the template for replication and transcrip-
tion of the genome; uncomplexed RNA cannot function
as a template for the viral polymerase. The RNA is
protected from ribonuclease attack and the nucleocapsid
may mask the genome from host cell surveillance via the
interferon response. The N protein thus has a multitude of
interactions for its functionality: with itself, the RNA, the
polymerase (L), and associated cofactors (e.g., the P
protein). In addition an interaction with the matrix (M)
protein may be responsible for the uptake of the nucleo-
capsid into the virion particle, as has been demonstrated
for human parainfluenza virus type 1 (hPIV1) and Sendai
virus (SeV) (Coronel et al., 2001). Attempts to map
domains on N proteins responsible for these interactions
have been made on a number of Mononegavirales mem-
bers, for example, rabies virus (RV) (Kouznetzoff et al.,
1998), SeV (Myers et al., 1999), measles virus (MV)
(Bankamp et al., 1996), and RSV (Garcia-Barreno et al.,
1996; Khattar et al., 2000; Murray et al., 2001). Although
differences exist between the viruses, the N proteins have
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a similar modular compartmentation of the interacting
regions. The amino-terminus appears to be responsible
for the assembly of the nucleocapsid, while the carboxyl-
terminus has elements that are necessary for the interac-
tion with the polymerase and the M protein.
The assembly of nucleocapsids has been best studied
on SeV, which appears to be an appropriate model for
other members of the Paramyxoviridae (Lamb and Ko-
lakofsky, 2001). The formation of the nucleocapsid is
coupled with genome replication; the N being delivered
possibly in the form of complex with P (NoP). The NoP
complex maintains N in a soluble state and promotes
specific binding to both viral genomic and antigenomic
RNA (Curran, 1996; Curran et al., 1995). For a number of
viruses within the Paramyxoviridae, sole expression of N
results in assembly of nucleocapsid-like structures
around cellular RNAs (Bhella et al., 2002); coexpression
of P protein apparently inhibits this effect (Spehner et al.,
1991; Curran et al., 1995).
Several groups have studied the interaction between
the RSV N and P proteins. Deletion of the carboxyl-
terminus of N, and monoclonal antibodies (Mabs) that
bind to this region, have a deleterious effect on the
interaction (Garcia-Barreno et al., 1996; Khattar et al.,
2000; Murray et al., 2001). The amino-terminus of the
RSV N has not been as well studied, although by analogy
to other mononegaviruses, it is likely that the RNA-
binding domain and the N–N interacting region are lo-
cated within this region (Heggeness et al., 1980; Myers et
al., 1997: Schoehn et al., 2001). Attempts to map func-
tional domains to the amino-terminus of RSV N have not
been overly successful, possibly due to altered confor-
mations of expressed proteins. Khattar et al. (2000) at-
tempted to determine the effect of deletion on the ability
of N to encapsidate a minigenome RNA using protection
from nuclease activity as an assay. Removal of the ami-
no-terminal eight amino acids apparently ablated encap-
sidation, but surprisingly, such a deletion had a minimal
effect on transcription and replication. It is likely, there-
fore, that the mutant N was still able to bind RNA and act
as a component of the template, but not able to convert it
into a nuclease resistant structure, a feature considered
one of the defining attributes of Mononegavirales nucleo-
capsids. Buchholz et al. (1993) observed a similar phe-
nomenon with the N of SeV.
In this article, we demonstrate that RSV N, when
expressed and purified from bacteria, binds RNA in a
non-sequence-specific manner and is able to form nucle-
ocapsid-like structures. The binding to RNA apparently
induces a conformational change in N. We show that the
RNA, and possibly the N–N, interacting domains reside
between amino acids 1 and 92 of N and that this region
is sufficient to form a structure where the RNA is resis-
tant to nuclease attack. We also show that the amino-
terminus of N has a region that may be involved with P.
Results and discussion
Generation of deletion mutants of the RSV N protein
The generation of full-length N protein with an amino-
terminal histidine tag (His-N) has previously been described
(Murray et al., 2001). A number of mutants (Fig. 1a),
primarily C-terminal truncations, were subsequently pre-
pared, using either PCR or the Promega Gene Editor kit.
The C-terminal mutants were a series deleting the N by
increments of 50 amino acids. Two mutants with deletions
in the amino-terminus of N were also constructed; N1-200
lacks the N-terminal 200 amino acids, while N121-160 rep-
resents an internal deletion of 40 amino acids. Expression of
the mutants and full-length His-N in BL21 (DE3) pLysS
was readily detected (Fig. 1b). Subsequent work on the
proteins demonstrated that a proportion of each was soluble
(ca. 10-30% depending on the clone). The majority of the
“insoluble” protein was subsequently determined to be oli-
gomers of His-N with the morphological appearance of
RSV nucleocapsids (see below), which were pelleted by the
initial high speed centrifugation prior to isolation of protein
using nickel affinity chromatography. Within the His-N,
N121-160, N342-391, and N292-391 preparations, we rou-
tinely observed a breakdown product of approximately 30
Fig. 1. (a) Graph of His-N and mutant proteins thereof. The deletion
mutants were named according to the amino acids removed by the mu-
tagenesis procedure. All the proteins were expressed and had an in-frame
histidine tag. (b) Western blot analysis of crude cell extracts of bacteria
expressing the proteins shown in (a). The lysates were separated by 12%
SDS–PAGE and transferred to nitrocellulose membranes. The proteins
were probed with an anti-histidine tag monoclonal conjugated to HRP;
captured antibody was visualised using ECL. * indicates the amino-termi-
nal breakdown product (N*) routinely observed in preparations of His-N
and in some of the mutants (see text).
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kDa (N*). This fragment could be detected with the His-tag
antibody or with Mabs directed against the amino-terminus
of N but not with Mabs against the carboxyl-terminus (not
shown). Thus similar to other N proteins the C-terminus of
the RSV N is susceptible to proteolytic removal (Heggeness
et al., 1980, 1981; Mountcastle et al., 1974; Schoehn et al.,
2001). We also observed that the smaller proteins (e.g.,
N92-391) had a propensity to form higher order oligomers
that were not readily dissociated by boiling in SDS–PAGE
loading buffer, suggesting that the first 92 amino acids may
have a role in the N–N interaction.
Full-length recombinant N binds RNA in a non-sequence-
specific manner
His-N was purified by nickel-affinity chromatography.
Size exclusion chromatography showed that under the con-
ditions used, the His-N preparations were largely mono-
meric protein with a small (5%) amount of dimer. Various
assays were used to test for RNA binding; however, when
RNA of any nature was added, His-N aggregated rapidly
and the majority of the complexes could not be adequately
resolved by gel electrophoresis, although there was some
indication of in vitro RNA binding (not shown). Addition of
a molar excess of RNA, to promote the binding of fewer
His-N molecules to each RNA molecule, did not alleviate
the situation, which suggested that interaction of even a
single His-N with an RNA molecule catalysed a cascade of
binding events, resulting in aggregation. The binding of
exogenously added RNA to His-N appeared inefficient pos-
sibly due to the presence of bacterial RNA already bound to
the protein. This was confirmed by UV traces obtained
during purification of His-N on an FPLC apparatus that
indicated that nucleic acid was extracted in the same frac-
tions as His-N (data not shown). As shown later (Fig. 4)
His-N can form nucleocapsid-like structures containing bac-
terial RNA. However, no evidence was found for the pres-
ence of nucleocapsid-like structures after examining His-N
preparations purified by nickel-affinity chromatography by
electron microscopy (EM). Thus a significant proportion of
the so-called soluble His-N must be bound to a small frag-
ment of RNA in a nuclease-protected form.
To overcome the interference caused by the presence of
bacterial RNA bound to His-N, we employed a modified
North–Western blot assay. This included a protein denatur-
ation and renaturation step so it was likely that incorporated
bacterial RNA would be removed. The ability of His-N to
bind RNA under these conditions was tested by the addition
of either radiolabelled specific RNA (representing the plus
leader strand) or a nonspecific RNA. As more RNA was
added, the binding to His-N increased. However we did not
observe any significant differences between the binding of
the two RNAs (Fig. 2a, i and ii). No binding to a control
protein (His-Gal) was observed.
To more fully explore this, a competition assay was
developed. Fragments of nitrocellulose membrane, contain-
ing His-N, were excised and incubated in RNA-binding
buffer containing a radiolabelled specific RNA probe and a
cold competitor probe at varying molar ratios (Fig. 2b, i).
The ability of the specific probe to compete with a radiola-
belled nonspecific probe was also tested (Fig. 2b, ii). The
relative intensities of captured probe, determined by densi-
tometry, were plotted after normalisation of the protein
levels bound to each fragment of membrane and of the
specific activity of each of the probes (Fig. 2b, iv). We saw
no significant differences between the two samples. A non-
RNA-binding protein, -galactosidase, was also tested (Fig.
2b, iii). At low competitor levels some degree of nonspecific
RNA binding was apparent, but at higher levels, unlike
His-N, no binding was detected. The pattern of binding
indicates that there were two distinguishable modes of in-
teraction between His-N and RNA in this assay. The major
form is largely nonspecific, represented by a large decline in
binding of the radiolabelled species in the presence of low
amounts of cold competitor. We believe this to be a result of
the RNA binding to His-N as a consequence of electrostatic
attraction with basic amino acid residues; we assume that
the His-N is present in both unfolded and folded forms, thus
the residues may come from anywhere within the protein.
The second form of binding appears to be of higher affinity,
as large excesses of cold competitor failed to dislodge RNA
from the N. We assume that this might represent RNA that
has located to the true RNA-binding domain on native
protein, and similar to the RNA bound to purified, mono-
meric N, this interaction would only be disrupted by protein
denaturation. Our data could see no significant differences
between the binding affinity of a specific and nonspecific
RNA to His-N. We could not, therefore, assign a sequence
specificity to the binding of RNA to RSV N, a feature that
is apparently shared with other mononegaviruses when N
proteins are expressed in the absence of other viral proteins
(Bankamp et al., 1996; Buchholz et al., 1993; Iseni et al.,
1998).
The RNA binding domain is located in the amino-
terminus of the RSV N protein
Attempts were made to use the deletion mutants in the
modified North–Western assay to determine the approxi-
mate locale of the RNA-binding domain. However, varia-
tion in expression levels and purity made the assay unman-
ageable. An alternative protocol employed the use of CsCl
density gradients and Trizol extraction of RNA. The gradi-
ents were fractionated and the presence of protein deter-
mined by Western blotting using an anti-His tag Mab (not
shown). The densities of fractions that contained protein
were determined by refractometry and by reference to pub-
lished tables and are listed in Table 1. We noted that there
was variation in the densities, but generally the mutants had
lower densities than that obtained for His-N or for N pre-
pared from RSV-infected CV-1 cells. However, all the den-
sities were significantly higher than that of BSA (1.19
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g/cm3). This suggested that all the mutants bound RNA,
although the ratio of RNA to protein was probably variable,
which may explain the variation in densities.
To test the assumption that RNA has been encapsidated
by His-N, or mutants thereof, the peak fractions were dia-
lysed into RIPA buffer and precipitated with an anti-His tag
Mab and recovery was confirmed by Western blot (not
shown). Nucleic acid within the potential RNP complexes
was recovered by Trizol extraction and end-labelled with
32P. TCA precipitable material was recovered from all of
the C-terminal mutants and N121-160 (Fig. 3). However,
N1-200, despite having a density higher than that of BSA,
had no detectable nucleic acid. When micrococcal nuclease
was added, after Trizol extraction, the radioactivity was
converted to an acid-soluble form, confirming that the re-
covered nucleic acid was RNA. This implies that the RNA-
binding domain of the RSV N protein, or at least significant
elements of it, is located within amino acids 1-92. Thus it
appears that the elements necessary for nucleocapsid for-
mation, similar to other members of the Paramyxoviridae,
are found within the amino-terminus of N (Bankamp et al.,
1996; Buchholz et al., 1993; Myers et al., 1997). The be-
Fig. 2. RNA binding by His-N shows no sequence specificity. (a) 50 g of His-N, isolated by Ni-affinity chromatography, was separated by SDS–PAGE in
an 8-cm well and Western blotted. After transference, the nitrocellulose was cut into 1-cm strips and subjected to North–Western blotting after renaturation
of the protein. Increasing amounts of radiolabelled RNA was added to each strip (indicated above) and allowed to bind. After washing, the strips were exposed
to a phosphorImager screen and scanned using a Bio-Rad phosphorImager with Quantity One software. Two different RNA probes were employed: (i) a
specific probe representing the RSV plus-strand Leader RNA and (ii) a nonspecific RNA probe. The last strip (*) was his--Gal probed with 50,000 cpm
of the appropriate probe. The smaller band noticeable in the strip exposed to 50,000 cpm of probe is N* (see Fig. 1). In all cases yeast tRNA was included
to inhibit nonspecific interactions. (b) Competitive North–Western using His-N. Small fragments of nitrocellulose containing renatured His-N were exposed
to a radiolabelled probe, either (i) the specific leader probe or (ii) the nonspecific probe. The binding of each probe was performed in competition with
increasing molar ratios of cold competitor. After binding, the strips were washed and exposed to a phosphorImager screen and scanned. After taking into
account protein levels (determined by Western blot of the fragments) and probe activities, the competition profiles were plotted (iv). As a control His--Gal
was probed with hot specific probe and cold nonspecific competitor (iii).
Table 1
Densities obtained by caesium chloride gradients for various N protein
mutants
Protein Density (g/cm3)
RSV N 1.31  0.02
N-His 1.30  0.02
N342–391 1.29  0.02
N292–391 1.29  0.02
N242–391 1.28  0.02
N192–391 1.28  0.02
N142–391 1.29  0.02
N92–391 1.28  0.02
N121–160 1.30  0.02
N1–200 1.26  0.03
BSAa 1.19  0.05
a Bovine Serum Albumin
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haviour of N1-200 raises the possibility that the RNA-
binding domain might be bipartite. The protein banded at a
density higher than BSA suggests the presence of bound
RNA, but no RNA could be extracted. N1-200 may bind
RNA nonspecifically; we note that our previous explanation
of RNA binding suggested that the majority observed in
vitro was due to nonspecific electrostatic interactions. Prior
to purification on CsCl gradients, the crude lysates were
subjected to RNase treatment to overcome such a problem.
However, it is apparent that the majority of the RNA-
binding ability of N is a feature of residues 1-92.
Formation of nucleocapsid-like structures as visualised by
electron microscopy
The observation that the carboxyl-terminal mutants, and
N121-160, bound RNA such that it was protected from
nuclease digestion suggested that the N proteins may form
nucleocapsid-like structures. The ability of Mononegavi-
rales N proteins to form such structures in the absence of
other viral protein has been documented previously (Bhella
et al., 2002; Fooks et al., 1993; Green et al., 2000; Iseni et
al., 1998; Mavrakis et al., 2002; Meric et al., 1994; Myers et
al., 1999; Spehner et al., 1991). The N mutants, and full-
length His-N, were separated on CsCl gradients, stained
with 1% (w/v) PTA, and visualised by transmission electron
microscopy (TEM). When visualised by TEM, His-N
formed two types of structure (Fig. 4). Nucleocapsid-like
structures similar to that formed in RSV-infected cells were
observed, as was a population of subnucleocapsid rings
(arrows). Our previous analysis of the N-RNA rings formed
when RSV N is expressed from recombinant baculoviruses
(Bhella et al., 2002) demonstrated that they were composed
of 10 subunits, similar to structures obtained by heterolo-
gous expression of VSV and RV N proteins (Green et al.,
2000; Iseni et al., 1998).
The C-terminal mutants also formed ordered structures
with similarities to RSV nucleocapsids and the majority
formed distinguishable ring structures. The largest deletion
mutants, N142-391 and N92-391, formed nucleocapsid-like
structures (Fig. 4a), suggesting that both the RNA binding
and the N self-interacting domains were found within amino
acids 1-92. The N121-160 mutant was particularly interest-
ing. Whereas most of the N proteins, not including N1-200,
produced nucleocapsid-like and ring structures, N121-160
produced only ring structures. This would suggest that he-
lical stability relies on more than lateral (i.e., side-by-side)
contacts and may involve interaction between N molecules
on adjacent turns of the helix and thus there may be up to six
contacts for any one subunit within a helix (see Fig. 4b);
thus a nucleocapsid could be considered a curved sheet with
N packed in a hexagonal arrangement. The N121-160 mu-
tation may disrupt an interaction between protein on adja-
cent turns, either by loss of one of the contacts or by
adopting a conformation that prevents an interaction occur-
ring. The result could be the inability of N121-160 to form
more than one helical turn or that the stability of helices is
decreased to such an extent that purification disrupts any
that may have existed. We have tried to visualise whether
N121-160 forms helices, within bacteria, but have not been
able to identify any such structures.
N1-200 formed neither nucleocapsid-like nor ring struc-
tures, but we observed aggregates of what we assume to be
N1-200. It could be that there may be an additional N–N
interaction site within amino acids 201-391 that allowed the
aggregation to occur. The possible bipartite nature of the
N–N interacting domain may also exist in MV N (Bankamp
et al., 1996).
Identification of sites of interaction for the P protein
We previously demonstrated, using Mabs and peptide
blocking studies, that there was a P-binding site in the N
protein carboxyl-terminus (Murray et al., 2001). Further
peptide studies were undertaken to determine whether the
amino-terminus was involved in any way with the P protein.
Peptides representing the amino-terminus from amino acids
1 to 252 (the region not covered previously) were used in
preliminary studies either to bind P to a solid support or to
block the binding of N to P (data not shown). N4 (amino
acids 46-65) demonstrated reasonable binding to P (Fig. 5a),
but in blocking assays had a dramatic effect on the binding
of N to P (Fig. 5b). Peptide N17 (amino acid 241-260)
bound P strongly but was unable to block the N–P interac-
tion. The binding was specific as P did not bind significantly
to other peptides nor did N4 and N17 bind control proteins
(not shown). The sequence of N4 and N17 are presented in
Fig. 5d.
Fig. 3. Radiolabelling of RNA extracted from potential RNP structures.
After expression and isolation on CsCl density gradients the N mutants
were immunoprecipitated by an anti-histidine tag Mab. The complexes
were treated with Trizol reagent, dephosphorylated, and end-labelled with
32P. The samples were either left untreated or digested with micrococcal
nuclease and precipitated with TCA and insoluble complexed captured
onto glass filters. The level of radioactivity from each sample was nor-
malised to protein levels that had been determined by Western blotting of
a portion of the sample prior to Trizol extraction.
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Expression of mutants containing these regions showed
that whereas the carboxy domain, as represented by N1-200,
could bind P, the amino-terminus, as represented by N192-392,
was unable to do so (Fig. 5c). It is possible that the N4
sequence at the amino-terminus, in the context of the full-
length protein, required the presence of the carboxyl-termi-
nus for functionality: use of the peptide in binding/blocking
experiments overcomes the requirement in vitro. We have
preliminary evidence, using tryptic digests and mass spec-
troscopy analysis, that the sequence represented by N4 on N
is exposed to the solvent and thus would be available for
some form of interaction (L.B. Murphy and P. Ashton,
unpublished observations). Since the sequence is within the
proposed nucleocapsid assembly domain and RNA-binding
domain, the interaction of P with this site could prevent
unsolicited assembly of N onto cellular RNAs. Similarly, it
has been reported for MV and HPIV-3 that there are at least
two regions involved in P binding, one in the amino-termi-
nus and another near the carboxyl-terminus (Bankamp et al.,
1996; Zhao and Banerjee, 1995). Caution must be applied to
such a comparison since the N proteins of the Pneumoviri-
nae are considerably smaller than their Paramyxovirinae
counterparts (ca. 43 kDa compared to 55 kDa and more).
However the results do indicate that separate elements make
Fig. 4. (a) Formation of nucleocapsid-like structures by His-N and the mutant proteins. The various proteins were extracted from bacteria by separating cell
lysates, previously treated with RNase and DNase, on a CsCl gradient. The appropriate bands were dialysed into NTE and dropped onto a carbon-coated grid
and stained with 1% PTA. The grids were then observed in a Phillips electron microscope at a nominal magnification of 32,000. Mutants N342-391 and
N242-391 are not included as we were not able to obtain preparations that were suitable for EM due to bacterial contamination. (b) A diagram of the RSV
nucleocapsid. The hexagonal order of the N within the helix is discernible, the N within the “core” of a hexagon may contact up to six other N molecules.
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up P-binding sites for both subfamilies. Whether these con-
stitute components of a single binding site, which is formed
by folding of N, or represent distinct functional sites is not
clear.
The domain structure of the RSV N protein
Figure 6 shows a proposed domain structure for the
hRSV N protein based on the above data and from previous
publications (Garcia-Barreno et al., 1996; Khattar et al.,
2000; Murray et al., 2001).
Khattar et al. (2000) investigated the N of bovine RSV
(bRSV), which shares approximately 93% homology at the
amino acid level with the human strain of RSV N protein.
Two domains were identified in the bRSV N protein car-
boxyl-terminus that were involved in an interaction with P,
represented by amino acids 244-290 and 338-364. Peptide
N17 lies within the 244-290 region and we had placed the
second P interacting domain at amino acids 305-335 (Mur-
ray et al., 2001), thus there is good agreement on the
arrangement of the P interacting domain(s), at least in the
carboxyl-terminus of N. Garcia-Barreno et al. (1996) had
also indicated that P bound hRSV N near amino acid 352.
We now show that there is a third potential region, between
Fig. 5. There is a possible P-interacting domain in the N protein’s amino-terminus. (a) Peptides N4 and N17 can bind P protein in vitro. The wells of a
microtitre plate (Immulon 2, Thermo Labsystems) were coated with saturating amounts of His-N, peptide N4, peptide N17, or a nonspecific peptide (BG,
supplied by H. Marsden, MRC Virology Unit, U.K.). His-P was added and allowed to bind. The plates were extensively washed and bound His-P was detected
using an anti-P Mab. (b) Peptide N4, but not N17, can block the N–P interaction. Microtitre plate wells were coated with His-P protein. The peptides were
added at varying concentrations before His-N was added. Bound His-N was detected using an anti-N Mab. 100% binding was taken as the level that the two
proteins interacted in the absence of peptide. Background was determined by omitting His-N. Peptide N16 (amino acids 226-245) was used as a negative
control, as in preliminary experiments it neither bound to His-P nor blocked the interaction. (c) The amino-terminus cannot bind P when expressed alone.
Two of the mutant constructs were tested for their ability to bind P. N1-200, which represents the carboxy region, and N192-391, which represents the
amino-terminus of N, were tested. As in (a) plates were coated with the appropriate protein and His-P added, the binding of which was determined using
an anti-P Mab. His--Gal was used as a negative control. (d) The sequences of peptides N4 and N17 are given with their amino acid location. The numbers
refer to the wt N sequence without any tags.
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amino acids 45 and 65, on N that may be involved in some
interaction with P, possibly as suggested above to prevent N
assembling on nonviral RNA.
Khattar et al. (2000) showed that deletions of only 28
amino acids at the carboxyl-terminus affect encapsidation of
viral RNA by the bRSV N. Our data differ in that N missing
75% of its backbone (amino acids 1-92) was able to form
structures that encapsidated RNA and formed nucleocapsid-
like structures, indicating that the minimal requirements for
assembly are contained within this small domain. The re-
mainder of the N probably plays a supporting role in struc-
tural integrity, interactions with other viral and cellular
components, and functionality. The differences between the
data can be explained by the fact that Khattar et al. (2000)
used a biological system dependent on replication, and
specifically, looked for the incorporation of a minigenome
RNA. It is possible that cellular RNAs were nonspecifically
incorporated but not detected. However, the observations of
Khattar et al. (2000) and the study presented here support
the concept of N having at least two domains, one for
nucleocapsid assembly/structure and the other essential for
the interaction with the polymerase and/or other factors.
The features on N shown in Fig. 6 represent only some of
the potential interactions that N must be involved in. The
complexity of Mononegavirales nucleocapsid assembly,
and indeed virion assembly, suggest that the N protein has
other interactions, for example, with the M protein for
packaging the nucleocapsid into the virion during the bud-
ding process. Preliminary data implicates the C-terminal
region in this role (R.P. Yeo, unpublished results). Using the
data above, and reagents developed previously (Murray et
al., 2001), we aim to model the RSV nucleocapsid and map
the N protein domains into three-dimensional space, rather
than the linear model presented in Fig. 6, in an attempt to




BamHI and T4 DNA ligase were purchased from Gibco-
BRL. The plasmid pET 16b was obtained from Novagen as
were the bacterial strains DH5 and BL12 (DE3) pLysS.
Primers for PCR were purchased from MWG Biotech; the
sequences are available on request. Reagents for RNA ex-
traction from RSV-infected CV-1 cells and reverse tran-
scription using random primers were obtained from Ambion
and Boehringer Mannheim, respectively. The proofreading
Pwo polymerase was used for PCR (Boehringer Mann-
heim). The Mabs to N and P have been described before
(Murray et al., 2001); the anti-mouse HRP conjugate and
the Mabs against the histidine tag were obtained from
Sigma.
Plasmid construction
The production of plasmids expressing histidine-tagged
versions of the RSV N (pETN) and P (pETP) proteins has
been previously described (Murray et al., 2001). pETN was
used as a template for the production of deletion mutants,
either by PCR or by using the Gene Editor mutagenesis kit
from Promega. Initially all constructs were transformed into
DH5 and sequences at their amino- and carboxyl-termini
were confirmed. Again, primer design was such that cloning
was in-frame with the pET 16b histidine tag. Plasmid DNA
was used to transform BL21 (DE3) pLysS; a number of
clones of each mutant were tested for expression before
selecting one for analysis.
Purification of his-tagged proteins
The expressed proteins were purified using Ni-affinity
chromatography. An overnight culture of each clone was
used to inoculate 100 ml YT broth and allowed to grow to
OD600 of 0.5 at 37°C before the addition of 1 mM ITPG.
After 3 h induction the bacteria were pelleted, resuspended
in phosphate buffer (20 mM sodium phosphate, 500 mM
NaCl pH 7.4), and lysed by three rounds of freeze/thaw in
a dry-ice/methanol bath. The lysate was treated with DNase
I and RNase A to reduce viscosity and clarified by centrif-
ugation at 85,000 g for 20 min. The his-tagged proteins
were isolated on a Hi-Trap chelating column (Pharmacia),
previously loaded with nickel, and eluted using increasing
concentrations of imidazole as per the manufacturer’s in-
structions. The eluted proteins were dialysed against PBS
Fig. 6. A model for the domain organisation of the RSV N protein based on our observations. The potential P-binding sites are represented by filled boxes,
while the region that may have a role in helical stability is represented by an open box.
150 L.B. Murphy et al. / Virology 307 (2003) 143–153
and stored at 4°C before use. As a control his-tagged -ga-
lactosidase (Novagen) was used.
Western blot analysis
Proteins, denatured by boiling in SDS-sample loading
buffer, were separated by SDS–PAGE. The proteins were
transferred to nitrocellulose membrane (Hybond-C, Amer-
sham) blocked with 5% (w/v) Marvel in PBS  0.1% (v/v)
Tween 20 and the proteins probed with an anti-his-tag
monoclonal (Sigma) which was conjugated to horseradish
peroxidase (HRP). Bound antigen-antibody was visualised
by ECL. All washes were carried out with PBS/Tween.
Production of radiolabelled RNA transcripts
Two 32P-labelled transcripts were prepared. One, termed
the “specific target,” represented the leader region of the
RSV antigenome, supposedly the site responsible for encap-
sidation. This was generated by annealing two complemen-
tary oligonucleotide primers that contained a T7 polymerase
promoter and the RSV leader sequence (Collins et al.,
1991). The nonspecific target was produced by linearising a
pBluescript KS plasmid with SstI. Runoff transcripts were
prepared using the Mega-Shortscript kit (Ambion). To pro-
duce radiolabelled RNAs, the cold CTP was replaced with
[32P]CTP. The RNA transcripts were purified on a 15%
polyacrylamide gel containing 6 M urea, eluted into TE
buffer with 0.1% (w/v) SDS, and precipitated using ethanol.
The RNAs were pelleted before use and resuspended in
RNase-free water.
North–Western analysis
The RNA-binding specificity of full-length His-N pro-
tein was analysed by North–Western blot protocol, modified
from that described by Blackwell and Brinton (1995). Fifty
micrograms of His-N was denatured and loaded into a
single 5-cm-wide lane on a 12% polyacrylamide gel, elec-
trophoresed, and transferred to nitrocellulose as above. The
membrane was blocked in 5% Marvel in PBS containing 1
mM DTT. The membrane was washed in HBB (25 mM
HEPES pH 7.5, 25 mM NaCl, 5 mM MgCl2, and 1 mM
DTT) to allow protein refolding to take place at 4°C for
16 h. The portion of the membrane containing the His-N
protein was cut up into small (5  3 mm) fragments and
inserted into 1.5-ml microtubes and covered with HYB100
buffer (20 mM HEPES–KOH, 100 mM KCl, 2.5 mM
MgCl2, 0.1 mM EDTA, 0.05% (v/v) Nonidet P-40, and 1
mM DTT) with 20,000 counts per minute (cpm) of the
appropriate RNA probe together with 1 g yeast tRNA
(Sigma) to reduce nonspecific binding and, when required,
a cold competitor RNA at various concentrations. RNA was
quantified by spectrophotometry. Binding was allowed to
take place overnight before washing the membranes exten-
sively in HYB100 buffer and exposing the blot to a phos-
phorImager screen (Bio-Rad). Band intensities were deter-
mined by densitometry using Bio-Rad Quantity One
software. Each band was boxed and the background, deter-
mined for each individual nitrocellulose fragment, was de-
termined. The level of binding was calculated by normalis-
ing to protein levels on each fragment (by Western blot) and
taking into account the specific activities of the probes used.
Isolation of recombinant nucleocapsid-like structures
The various N proteins were expressed as above. After
pelleting the bacteria, they were resuspended in NTE buffer
(150 mM NaCl, 50 mM Tris–HCl pH 7.4, 2 mM EDTA). A
1/10 volume of 6% (v/v) NP-40 in NTE was added and the
cells were subjected to three rounds of freeze/thaw. The
lysate was clarified by centrifugation at 12,000 g for 20 min.
The clarified lysate was layered on top of a linear 25-40%
CsCl gradient, prepared in NTE, and centrifuged in a TST41
rotor (Sorvall) at 200,000 g for 18 h at 16°C. Bands were
visualised by light scattering and isolated by side puncture.
The bands were dialysed against NTE and used for EM
analysis (see below). The RNP-like structures were also
precipitated by an anti-histidine tag Mab before RNA ex-
traction methodologies were employed.
Density gradient analysis
An alternative to linear gradients was to isolate RNP
using buoyant density equilibrium centrifugation to deter-
mine the density of the nucleocapsids. The constructs were
expressed as above and the clarified lysate layered on top of
a CsCl step gradient (2 ml 40%, 2 ml 30%, 2 ml 25%,
topped with a 2.5 ml 5% sucrose solution) and centrifuged
at 200,000 g for 2 h in a TST41 rotor. The 30% band was
isolated and the volume increased to 5 ml with 30% CsCl;
the density of the solution was checked by refractometry.
The solution was rebanded to equilibrium by centrifugation
in a AH650 rotor at 150,000 g for 36 h at 16°C. The
gradients were fractionated from the top and each fraction
was subjected to Western blot analysis to detect the his-
tagged proteins; the density of each fraction was determined
by refractometry.
Detection of RNA from recombinant nucleocapsid-like
structures
Prior to isolating the RNA, to ensure that only N-struc-
tures were the source, the RNPs from above were precipi-
tated by an anti-histidine tag antibody (Sigma). RNA was
recovered by extraction using Trizol LS (Invitrogen) as per
the manufacturer’s instructions. Recovered RNA was
treated with calf intestinal alkaline phosphatase to remove
5 phosphate groups and then subsequently end-labelled
with 32P using T4 polynucleotide kinase. Each sample was
divided into two; one was left untreated, and the other was
digested with micrococcal nuclease in the presence of cal-
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cium. After treatment, 10 volumes of ice-cold 10% (w/v)
trichloroacetic acid was added and the samples were cap-
tured on glass filters (Sigma) which were washed with 5 ml
of 10% (w/v) trichloroacetic acid. Captured radioactivity
was measured by scintillation counting.
Electron microscopy
The bands obtained from the linear gradients were
mounted on carbon-coated copper grids and stained using a
1% (w/v) phosphotungstic acid (PTA) stain. The grids were
analysed in a Phillips 100 V electron microscope at a nom-
inal magnification of 32,000.
Protein binding and competition assay
Microtitre plates were coated with peptides (Murray et
al., 2001) or appropriate protein. His-P protein was added in
saturating quantities, determined empirically, and allowed
to bind. After washing, the His-P was detected using a P
Mab and an anti-mouse HRP conjugate. ABTS (1 mg/ml;
Sigma) color reagent in 50 mM citrate buffer (pH 4.0) with
hydrogen peroxide was added to each well and the color
reaction allowed to proceed for up to 30 min at room
temperature. All binding and wash steps were performed in
PBS containing 0.1% Tween 20. The plates were analysed
on a Dynex microtitre plate reader at a wavelength of 405
nm. The blocking assays were carried out in a similar
manner except that His-P was used to coat the plate. Pep-
tides were added, before addition of His-N, at varying
concentrations from 1-100 g/ml in PBS or water. After
allowing the peptides to bind, His-N was added in saturating
quantities and allowed time to interact. Captured His-N was
detected using a N Mab followed by an anti-mouse HRP
conjugate.
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